Il Dong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Il Dong Pharmaceutical Co Ltd cash flow reinvestment rate. Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow Reinvestment Rate of 0.65x as of September 2025, reinvesting ₩7.32 Billion (capex ₩5.97 Billion plus investments ₩-1.35 Billion) from operating cash flow of ₩11.28 Billion. See financial flexibility index of Il Dong Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Il Dong Pharmaceutical Co Ltd (2016–2024)
Cash flow reinvestment rate of Il Dong Pharmaceutical Co Ltd from 2016 to 2024. Historical reinvestment intensity for Il Dong Pharmaceutical Co Ltd across 6 annual periods. Explore Il Dong Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Il Dong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2016–2024)
Il Dong Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2016 to 2024. Year-by-year capital reinvestment analysis for Il Dong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 249420 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.95x | ₩26.81 Billion | ₩28.29 Billion | ₩14.05 Billion | ▲ +10.6% |
| 2020 | 0.86x | ₩16.59 Billion | ₩19.37 Billion | ₩14.35 Billion | ▲ +138.1% |
| 2019 | 0.36x | ₩14.89 Billion | ₩41.37 Billion | ₩12.06 Billion | ▲ +42.4% |
| 2018 | 0.25x | ₩16.85 Billion | ₩66.65 Billion | ₩15.09 Billion | ▼ -32.8% |
| 2017 | 0.38x | ₩27.71 Billion | ₩73.72 Billion | ₩16.73 Billion | ▼ -38.3% |
| 2016 | 0.61x | ₩28.01 Billion | ₩45.98 Billion | ₩14.22 Billion | — |